Netto GJ, Amin MB, Comperat EM, Gill AJ, et al. Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol 2023;83:301-303.
PMID: 36202687